Trial intelligence / Profile preview

Azithromycin SR vs Augmentin ES-600 for Acute Otitis Media in Children

NCT00643292Phase 3Completed

Sponsor
Pfizer
Start
Jan 2003
Modality
Small Molecules
Countries
13
01

Overview

A Phase 3 trial of azithromycin in acute otitis media (AOM), sponsored by Pfizer. Started Jan 2003; status: completed.

02

Drugs

azithromycin
03

Conditions

acute otitis media (AOM)

Beyond the preview

Go deeper on NCT00643292.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00643292.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call